Shares of Gilead Sciences Inc. advanced 7.46% to $103.31 Wednesday, on what proved to be an all-around poor trading session ...

The S&P 500 dipped on Wednesday as a hotter-than-expected U.S. inflation reading added to worries that the Federal Reserve ...

U.S. stocks are sinking after a report said inflation is unexpectedly getting worse for Americans. The S&P 500 fell 0.9% in ...

Robinhood reported fourth-quarter revenue of $1.01 billion, up 115% year-over-year and a new company record. The revenue ...

Ideaya Biosciences (IDYA) announced it has entered into an additional clinical study collaboration and supply agreement with Gilead Sciences ...

BofA raised the firm’s price target on Gilead (GILD) to $116 from $109 and keeps a Buy rating on the shares. Q4 results “handily beat ...

The S&P 500 ended down on Wednesday after a hotter-than-expected US inflation reading added to worries that the Federal ...

U.S. consumer prices increased in January by the most in nearly a year and a half. The surge offered a cautionary note to Trump's push for tariffs.

U.S. stocks mostly fell as inflation worsens, with the S&P 500 down 0.3% and the Dow dropping 225 points. Inflation pressures ...

The S&P 500 dropped 0.3% on Wednesday, Feb. 12, as hotter-than-expected inflation data in the January CPI report weighed on the interest rate outlook.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...